Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.

Further Reading

Astellas, Potenza collaborate to develop immuno-oncology therapeutics for patients with certain cancers

Astellas, Potenza collaborate to develop immuno-oncology therapeutics for patients with certain cancers

22 Apr 2015
Cantrixil drug granted FDA Orphan Drug Designation for treatment of ovarian cancer

Cantrixil drug granted FDA Orphan Drug Designation for treatment of ovarian cancer

22 Apr 2015
New mathematical model to predict pharmacodynamic activity may help improve drug discovery

New mathematical model to predict pharmacodynamic activity may help improve drug discovery

21 Apr 2015
CiRA, Takeda collaborate to develop clinical applications of iPS cells

CiRA, Takeda collaborate to develop clinical applications of iPS cells

17 Apr 2015
Optibrium to integrate ChemAxon's Plexus with StarDrop software platform

Optibrium to integrate ChemAxon's Plexus with StarDrop software platform

15 Apr 2015
Clyde Biosciences, a leading drug toxicity testing company, closes Series A investment

Clyde Biosciences, a leading drug toxicity testing company, closes Series A investment

14 Apr 2015
New pre-validated fluorinated fragment library boosts drug screening efficiency

New pre-validated fluorinated fragment library boosts drug screening efficiency

From Thermo Fisher Scientific Inc. 14 Apr 2015
JPK reports on the use of the NanoWizard® 3 AFM system at the Hebrew University of Jerusalem

JPK reports on the use of the NanoWizard® 3 AFM system at the Hebrew University of Jerusalem

From Bruker BioAFM 14 Apr 2015
Scientists identify chemical compounds that block cancer-causing oncoprotein

Scientists identify chemical compounds that block cancer-causing oncoprotein

10 Apr 2015
UQDI reveals that Anisina drug can kill melanoma cells

UQDI reveals that Anisina drug can kill melanoma cells

9 Apr 2015
Vanderbilt researchers join multi-center effort to accelerate development of potential Ebola therapy

Vanderbilt researchers join multi-center effort to accelerate development of potential Ebola therapy

9 Apr 2015
Sanford-Burnham, Daiichi Sankyo sign licensing agreement to expand development of small molecule

Sanford-Burnham, Daiichi Sankyo sign licensing agreement to expand development of small molecule

6 Apr 2015
Aptuit increases API capacity to meet increased demand for integrated candidate-to-IND solutions

Aptuit increases API capacity to meet increased demand for integrated candidate-to-IND solutions

3 Apr 2015
Novogen appoints PCG Advisory to manage investor-awareness program in the US

Novogen appoints PCG Advisory to manage investor-awareness program in the US

2 Apr 2015
Novel molecule inhibits cancer-causing transcription factors

Novel molecule inhibits cancer-causing transcription factors

2 Apr 2015
Selvita commences IND-enabling studies for its first oncology drug candidate

Selvita commences IND-enabling studies for its first oncology drug candidate

1 Apr 2015
Aeterna Zentaris inks Material Transfer Agreement with MUSC

Aeterna Zentaris inks Material Transfer Agreement with MUSC

31 Mar 2015
Broad Institute expands collaboration with Bayer to develop new cardiovascular therapies

Broad Institute expands collaboration with Bayer to develop new cardiovascular therapies

31 Mar 2015
Cantrixil proves highly effective at killing human ovarian stem cells in pre-clinical study

Cantrixil proves highly effective at killing human ovarian stem cells in pre-clinical study

30 Mar 2015
Fujifilm enters into definitive agreement to acquire Cellular Dynamics International

Fujifilm enters into definitive agreement to acquire Cellular Dynamics International

30 Mar 2015

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback